Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat ...

Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, ...

The FDA has approved Novartis Coartem Baby, the first malaria treatment designed for newborns and young infants. The medicine, developed in collaboration with Medicines for Malaria Venture, a ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, Ekterly, for a type of ...

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...

KalVista Pharma has finally received FDA approval for its oral kallikrein inhibitor sebetralstat, becoming the first ...

The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...

Novartis has won approval in Switzerland for the world’s first malaria drug for newborns and infants, creating a new weapon ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares ...